导出类型

 

Neuroimaging Clin N Am 2017 May;27 (2): 195-204. 全文索取
Multiple Sclerosis: Epidemiologic, Clinical, and Therapeutic Aspects.

Abstract
Multiple sclerosis (MS) is a chronic autoimmune and degenerative disease of the central nervous system that affects young people. MS develops in genetically susceptible individuals exposed to different unknown triggering factors. Different phenotypes are described. About 15% of patients present with a primary progressive course and 85% with a relapsing-remitting course. An increasing number of disease-modifying treatments has emerged. Although encouraging, the number of drugs challenges the neurologist because each treatment has its own risk-benefit profile. Patients should be involved in the decision-making process to ensure good treatment and safety monitoring adherence.

PMID: 28391781 [Pubmed - In-Process]

  • Full Text Sources

关联文献

  • 加载中....

检索记录[清空]